New Key Statistics Module, Z-Score and F-Score
NAS:IART Key Ratios
Market Cap $ M | 2,270.82 |
Enterprise Value $ M | 3,643.41 |
P/E(ttm) | 34.81 |
PE Ratio without NRI | 10.90 |
Forward PE Ratio | 9.03 |
Price/Book | 1.42 |
Price/Sales | 1.50 |
Price/Free Cash Flow | 31.44 |
Price/Owner Earnings | 68.46 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,541.00 |
EPS (TTM) $ | 0.83 |
Beneish M-Score | -2.57 |
10-y EBITDA Growth Rate % | 11.80 |
5-y EBITDA Growth Rate % | 8.10 |
y-y EBITDA Growth Rate % | -30.30 |
EV-to-EBIT | 27.51 |
EV-to-EBITDA | 14.23 |
PEG | 1.35 |
Shares Outstanding M | 78.60 |
Net Margin (%) | 4.39 |
Operating Margin % | 7.24 |
Pre-tax Margin (%) | 5.26 |
Quick Ratio | 2.18 |
Current Ratio | 3.45 |
ROA % (ttm) | 1.79 |
ROE % (ttm) | 4.07 |
ROIC % (ttm) | 2.86 |
Dividend Yield % | -- |
Altman Z-Score | 1.73 |
IART Number of Guru Trades
IART Volume of Guru Trades
Gurus Latest Trades with NAS:IART
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IART is held by these investors
Total 3
Integra Lifesciences Holdings Corp Insider Transactions
No Available Data
News about NAS:IART
Total 0- 1